Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × gilteritinib × 90 days × Clear all

NCT07140016 2026-03-04

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung